Conferences - The 2017 International COPD Conference

The 2017 International COPD Conference
Location:
Philadephia, PA
Date:
November 15, 2017
Cost:
Physicians - $195
Fellows, Residents and other healthcare practitioners - $135
Industry attendees - $135
Brochures and mail-in forms: PDF 2017_International_COPD_Conference_F817.pdf  

Please register early; on-site registration is $45.00 higher than pre-registration cost

  

INVESTIGATING THE CHANGING FACE OF COPD

A one-day comprehensive educational symposium on the most controversial topics in the diagnosis, management and treatment of COPD.

CONFERENCE DIRECTOR

Gerard J. Criner, MD, FACP, FACCP

Chair and Professor, Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University

WHO SHOULD ATTEND

All healthcare providers involved in the care and management of patients with COPD

 

Registration

Accreditation

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Ganésco, Inc. Global is accredited by the ACCME to provide continuing medical education for physicians.

* This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 7.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Nursing Continuing Education

Global Education Group is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s COA.

This educational activity for 7.25 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Nurse Practitioner Continuing Education

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and Ganésco. Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education.

Provider number: 1561024. This activity is approved for 7.25 contact hour(s). Pharmacology hours to be determined upon clinical review.

Activity ID #2437L

This activity was planned in accordance with AANP CE Standards and Policies.

Respiratory Care Continuing Education

Application has been made to the American Association for Respiratory Care (AARC) for 7.25 continuing respiratory care education (CRCE) contact hours for respiratory therapists.

Instructions for Obtaining Credit

In order to receive credit, participants must attend the activity and submit the credit application and evaluation form, per instructions given at the meeting. Statements of credit will be emailed typically within 6 weeks following the program.

Disclosure of Conflicts of Interest

Global Education Group (Global) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity.

All identified conflicts of interest are thoroughly vetted by Global for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Americans with Disabilities Act

 

Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact nancyn@ganesco.com prior to the live event.. For information about the accreditation of this program, please contact Global at 303-395-1782 or inquire@globaleducationgroup.com.

Information

The host hotel for this meeting is the Westin Philadelphia.

Please use the following link to book your hotel:

https://www.ganesco.com/starwoodforgold

If you would rather call the hotel to make your reservation, reference the name of the Conference. 

The discounted room rate is available if booked by 5PM, October 21, 2017.

 

The Westin Philadelphia

99 South 17th Street at Liberty Place

Philadelphia, PA 19103 United States

 Phone: 215.563.1600

 

Agenda

The 2017 International COPD Conference "Investigating the Changing Face of COPD" is a one-day comprehensive educational symposium on the most controversial topics in the diagnosis, management and treatment of COPD.

Wednesday, November 15th

Exhibits will be open during registration, breaks and lunch. Please make sure to check in at the beginning of the conference to ensure that proper credit can be provided.

6:30 - 7:45

Registration and Exhibits

7:45 - 8:00

Opening Remarks: Welcome and Accreditation Information

Gerard Criner, MD

Session I

The Diagnosis and Assessment of COPD

Moderator: Claus Vogelmeier, MD

8:00 - 8:30

Is Airflow Obstruction Essential to Diagnose and Treat COPD?

Bartolome R. Celli, MD (Pro); Robert A. Stockley, MD (Con)

8:30 - 8:50

What Symptoms are Pivotal in the Assessment and Treatment Of COPD?

Claus Vogelmeier, MD

8:50 - 9:10

Role of Chest Imaging in the Diagnosis and Treatment of COPD.

  • Airway Predominant vs Emphysema and its Impact on Prognosis And Treatment
  • Patterns of Emphysema and Its Impact on Prognosis and Treatment
  • Assessment of The Pulmonary Vasculature and Vascular Calcification In COPD

George R. Washko, M.D., M.M.Sc.

Session II

Risk Factors for the Development of COPD

Moderator: Alvar G. Agusti, MD

9:10 - 9:40

Host factors (Genetic Factors and Childhood Illnesses)

Alvar G. Agusti, MD

9:40 - 10:10

Biomass Exposure vs Active and Passive Cigarette Smoking

Jean Bourbeau, MD

10:10 - 10:40

Break and Exhibits

10:40 - 10:55

Risk Factors for the Development of COPD: Childhood and Adolescent Asthma

Jeffery M. Ewig, MD

10:55 - 11:10

Impact of Gender on COPD Development

Meilan K. Han, M.D., M.S.

11:10 - 11:25

Aging and COPD

Shawn Aaron, MD

Session III

Treatment of COPD

Moderator: Fernando J. Martinez, MD

11:25 - 11:45

Is Personalized Treatment a Viable Goal?

Gerard Criner, MD (Pro); Fernando J. Martinez, MD (Con)

11:45 - 12:05

Maximal Bronchodilation at Initiation of Therapy vs Progressive Bronchodilation?

Dennis E. O’Donnell, MD (Pro); Jean Bourbeau, MD (Con)

12:05 - 1:05

Lunch and Exhibits

1:05 - 1:25

ICS Have a Role in the Therapy of COPD

Antonio Anzueta, MD (Pro); Roberto Rodriguez-Roisin, MD (Con)

1:25 - 1:45

Peripheral Eosinophils are a Useful Biomarker in COPD

Ian Pavord, MD (Pro); Leonardo M. Fabbri, MD (Con)

Session IV

Exacerbations

Moderator: Robert A. Stockley, MD

1:45 - 2:15

A New Definition of COPD Exacerbation is Needed

Alvar G. Agusti, MD (Pro); Roberto Rodriguez-Roisin, MD (Con)

2:15 - 2:45

Determining the Cause of Exacerbation- Does it Matter?

Bartolome R. Celli, MD (Pro); Jean Bourbeau, MD (Con)

2:45 - 3:15

Biomarkers Can Be Useful in Identifying and Treating Exacerbation Events

Mona Bafadhel, MD (Pro); David Halpin (Con)

3:15 - 3:45

Break and Exhibits

Session V

Treatment of Exacerbations

Moderator: Robert A. Stockley, MD

3:45 - 4:15

Exacerbations Can be Totally Prevented

Fernando J Martinez, MD (Pro); Robert A. Stockley, MD (Con)

4:15 - 4:45

Pulmonary Treatment of Exacerbations is Currently Adequate

Antonio Anzueto, MD (Pro); Gerard Criner, MD (Con)

4:45 - 5:15

Non-pulmonary Treatment and Prevention of Acute Exacerbation is Useful

Leonardo M. Fabbri (Pro); David Halpin, MD (Con)

5:15 - 6:45

Post Conference Reception

 

Cancellation Policy

Your registration is refundable if you notify Ganésco by fax (904.212.2044) or by phone (412.370.1749) at least seven (7) days before the meeting.

 

Faculty Speakers

Shawn Aaron, MD_Professor of Medicine, University of Ottawa; Senior Scientist at the Ottawa Health Research Institute; Chief, Division of Respiratory Medicine, Ottawa Hospital, Ottawa, Ontario, Canada 

Alvar G. Agustí, MD, PhD_Associate Professor of Medicine, University of Barcelona; Director, Thorax Institute, Hospital Clinic, Barcelona, Spain

Antonio R. Anzueto, MD_Professor, Department Pulmonary Diseases and Critical Care Medicine Graduate School of Biomedical Sciences University of Texas Health San Antonio; Chief of Pulmonary Section, South Texas Veterans Health Care System, San Antonio, TX

Mona Bafadhel, MRCP_Nuffield Professor of Medicine, Nuffield Department of Medicine, University of Oxford, Henry Wellcome Building for Molecular Physiology, Headington, Oxford, United Kingdom

Jean Bourbeau, MD_Professor of Medicine, Departments of Medicine and Epidemiology & Biostatistics at McGill University; Director, McConnell Centre for Innovative Medicine (CIM), Research Institute of the McGill University Health Centre (RI-MUHC), Montreal, Quebec, Canada

Bartolome R. Celli, MD_Lecturer on Medicine, Harvard Medical School; Brigham and Women’s Hospital, Pulmonary Division, Boston, MA

Gerard Criner, MD_Professor of Medicine, Lewis Katz School of Medicine, Temple University School of Medicine, Chair, Department of Thoracic Medicine & Surgery, Co-Director Center for Inflammation and Lung Research, Medical Director, Pulmonary Service Line, Temple University Hospital, Philadelphia, PA

Jeffery M. Ewig, MD_Attending Physician, Pediatric Pulmonology, Children's Hospital of Philadelphia; Clinical Professor, Pediatrics, University of Pennsylvania, PA

Leonardo M. Fabbri, MD_Professor of Respiratory Medicine, Director of the Section of Respiratory Diseases and of the Department of Oncology, Hematology and Respiratory Diseases of the University of Modena and Reggio Emilia, Modena, Italy

David Michael George Halpin, MD_Consultant Physician, Royal Devon & Exeter Hospital; Honorary Associate Professor, University of Exeter, Devon, United Kingdom

Meilan K. Han, MD, MS_Associate Professor of Internal Medicine in the Division of Pulmonary and Critical Care Medicine; Medical Director of the Women's Respiratory Health Program at the University of Michigan Health System, Ann Arbor, MI

Fernando J. Martinez, MD_Executive Vice Chair of Medicine, Gladys and Roland Harriman Professor of Medicine Joan and Sanford I. Weill Cornell Medical College and New York-Presbyterian Hospital/Weill Cornell Medical Center, New York, NY

Dennis E. O’Donnell, MD_Professor of Medicine, Departments of Biomedical & Molecular Sciences (Physiology), Rehabilitation Medicine and Kinesiology & Health Studies, Queen’s University, Kingston, Ontario, Canada

Ian Pavord, MD_Professor of Respiratory Medicine, Nuffield Department of Medicine, University of Oxford, Headington, Oxford, United Kingdom

Roberto Rodriguez Roisin, MD_Professor Emeritus of Medicine, Universitat de Barcelona, Department of Pulmonary Diseases, Hospital Clinic Vilarroel, Barcelona, Spain

Robert A. Stockley, MD_Professor of Medicine, Birmingham University; Medical Director of the Lung Resource Centre, Queen Elizabeth Hospital; Director of Research and Development for the University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom

Claus Vogelmeier, MD_Professor of Internal Medicine and Head, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Germany School of Medicine, Marburg, Germany

George R. Washko, Jr, MD, MMSc_Assistant Professor of Medicine, Harvard Medical School; Brigham and Women's Hospital Pulmonary Division, Boston, MA